 PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multiproduct medical device company, today announced it has received formal notification from the Nasdaq Stock Market LLC Nasdaq of compliance with Nasdaq Listing Rule 5550a2 after 10 consecutive days with a closing bid price of at least 1 per share. We are pleased to have regained full compliance with Nasdaqs continued listing requirements, said Lishan Aklog, M.D., PAVmeds Chairman and Chief Executive Officer. PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. 